Hetero Drugs Withdrawn
CEP Certificates (EDQM COS List)
Hetero Drugs Withdrawn
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 19
- Latest End Date 2023-11-02
- Data Source EDQM
- Last Updated 2020-02-21
Company Overview
Social Profiles
Company Snapshot
Hetero Drugs Withdrawn
7-2-A2, Hetero Corporate Industrial Estates, Sanath Nagar Hyderabad,Telangana
India
www.hetero.com/ contact@heterodrugs.com View on MapCEP Records Timeline (19 records)
Product
Lisinopril dihydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2012-370 - Rev 00
Substance No.
1120
Issue Date
2020-02-21
End Date
2023-10-12
Country
India
Identifiers
Certificate No.: R1-CEP 2012-370 - Rev 00
Substance No.: 1120
Product
Itraconazole
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2005-289 - Rev 01
Substance No.
1335
Issue Date
2017-09-04
End Date
2018-05-24
Country
India
Identifiers
Certificate No.: R1-CEP 2005-289 - Rev 01
Substance No.: 1335
Product
Sertraline hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2010-059 - Rev 01
Substance No.
1705
Issue Date
2017-09-04
End Date
2021-07-27
Country
India
Identifiers
Certificate No.: R1-CEP 2010-059 - Rev 01
Substance No.: 1705
Product
Lansoprazole
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2010-088 - Rev 01
Substance No.
2219
Issue Date
2017-05-18
End Date
2020-12-01
Country
India
Identifiers
Certificate No.: R1-CEP 2010-088 - Rev 01
Substance No.: 2219
Product
Rizatriptan benzoate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2013-235 - Rev 00
Substance No.
2585
Issue Date
2016-05-31
End Date
2020-09-08
Country
India
Identifiers
Certificate No.: R0-CEP 2013-235 - Rev 00
Substance No.: 2585
Product
Ziprasidone hydrochloride monohydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2012-246 - Rev 01
Substance No.
2421
Issue Date
2015-10-09
End Date
2018-09-20
Country
India
Identifiers
Certificate No.: R0-CEP 2012-246 - Rev 01
Substance No.: 2421
Product
Valsartan, Process III
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2016-069 - Rev 00
Substance No.
2423
Issue Date
2022-01-20
End Date
2022-07-12
Country
India
Identifiers
Certificate No.: R1-CEP 2016-069 - Rev 00
Substance No.: 2423
Product
Pioglitazone hydrochloride
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2012-363 - Rev 00
Substance No.
2601
Issue Date
2019-07-17
End Date
2019-07-30
Country
India
Identifiers
Certificate No.: R1-CEP 2012-363 - Rev 00
Substance No.: 2601
Product
Telmisartan
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2011-272 - Rev 03
Substance No.
2154
Issue Date
2019-07-09
End Date
2019-07-30
Country
India
Identifiers
Certificate No.: R0-CEP 2011-272 - Rev 03
Substance No.: 2154
Product
Pioglitazone hydrochloride, Process II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2017-013 - Rev 01
Substance No.
2601
Issue Date
2019-04-05
End Date
2019-07-30
Country
India
Identifiers
Certificate No.: R0-CEP 2017-013 - Rev 01
Substance No.: 2601
Product
Quetiapine Fumarate, Process III
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2017-179 - Rev 00
Substance No.
2541
Issue Date
2019-02-15
End Date
2023-02-21
Country
India
Identifiers
Certificate No.: R0-CEP 2017-179 - Rev 00
Substance No.: 2541
Product
Nevirapine
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2008-145 - Rev 02
Substance No.
2255
Issue Date
2018-02-08
End Date
2023-11-02
Country
India
Identifiers
Certificate No.: R1-CEP 2008-145 - Rev 02
Substance No.: 2255
Product
Candesartan cilexetil
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2016-110 - Rev 00
Substance No.
2573
Issue Date
2018-01-26
End Date
2019-07-30
Country
India
Identifiers
Certificate No.: R0-CEP 2016-110 - Rev 00
Substance No.: 2573
Product
Valsartan, Process-II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2012-296 - Rev 02
Substance No.
2423
Issue Date
2017-08-10
End Date
2018-05-25
Country
India
Identifiers
Certificate No.: R0-CEP 2012-296 - Rev 02
Substance No.: 2423
Product
Terbinafine hydrochloride
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2006-148 - Rev 02
Substance No.
1734
Issue Date
2017-08-10
End Date
2022-08-25
Country
India
Identifiers
Certificate No.: R1-CEP 2006-148 - Rev 02
Substance No.: 1734
Product
Stavudine
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2008-162 - Rev 02
Substance No.
2130
Issue Date
2017-08-10
End Date
2019-09-16
Country
India
Identifiers
Certificate No.: R1-CEP 2008-162 - Rev 02
Substance No.: 2130
Product
Levetiracetam, Form I, LET Process
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2014-072 - Rev 02
Substance No.
2535
Issue Date
2016-08-31
End Date
2018-05-18
Country
India
Identifiers
Certificate No.: R0-CEP 2014-072 - Rev 02
Substance No.: 2535
Product
Valsartan
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2011-246 - Rev 01
Substance No.
2423
Issue Date
2015-09-29
End Date
2017-09-08
Country
India
Identifiers
Certificate No.: R0-CEP 2011-246 - Rev 01
Substance No.: 2423
Product
Levetiracetam, Form-I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2011-353 - Rev 02
Substance No.
2535
Issue Date
2015-09-29
End Date
2018-05-18
Country
India
Identifiers
Certificate No.: R0-CEP 2011-353 - Rev 02
Substance No.: 2535
Status Breakdown
19 total- Withdrawn by holder
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
India
Identifiers
Certificate No.: R1-CEP 2012-370 - Rev 00
Substance No.: 1120
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.